Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Chinese Patent Office
Federal Trade Commission
Harvard Business School
Dow
Fish and Richardson
McKesson
Johnson and Johnson

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208870

« Back to Dashboard

NDA 208870 describes DRAX EXAMETAZIME, which is a drug marketed by Jubilant Draximage and is included in one NDA. It is available from one supplier. Additional details are available on the DRAX EXAMETAZIME profile page.

The generic ingredient in DRAX EXAMETAZIME is technetium tc-99m exametazime kit. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the technetium tc-99m exametazime kit profile page.
Summary for 208870
Tradename:DRAX EXAMETAZIME
Applicant:Jubilant Draximage
Ingredient:technetium tc-99m exametazime kit
Patents:0
Pharmacology for NDA: 208870
Mechanism of ActionRadiopharmaceutical Activity
Suppliers and Packaging for NDA: 208870
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DRAX EXAMETAZIME technetium tc-99m exametazime kit POWDER;INTRAVENOUS 208870 NDA Jubilant DraxImage Inc. 65174-200 65174-200-05 5 VIAL in 1 CARTON (65174-200-05) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (65174-200-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INTRAVENOUSStrengthN/A
Approval Date:Aug 17, 2017TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fuji
Cantor Fitzgerald
Julphar
Covington
Federal Trade Commission
Colorcon
Daiichi Sankyo
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.